Архив объединяет доклады профессора Селима Исбира и соавторов на международных конгрессах. Фильтр по годам помогает найти названия встреч, даты, авторов и аннотации, а также перейти к оригинальным источникам при наличии ссылки.
ФИЛЬТР ПО ГОДУ:
1) Isbir CS, Daly RC, Mullany CJ, Dearani J, Orzsulak TA, McGregor CGA. Use of the internal mammary artery improves results of the combined aortic valve replacement and coronary artery bypass grafting. AHA 71st Scientific Sessions (Dallas, 8–11 Kas 1998). Circulation, 98(17) Suppl I-474, 1997.
Link: link yok
2) Isbir CS, Doğan R, Demircin M, Paşaoğlu İ. The effect of Aprotinin in ischemia-reperfusion injury: Role of membrane bound enzymes. 8th International Symposium on Cardiovascular Pharmacotherapy (Amsterdam, 28 Mar–1 Nis 1999). Cardiovasc Drugs Ther 13(1):48, 1999. Link: link yok
3) Isbir CS, Doğan R, Tuncer M, Farsak B, Kılınç K, Aydın M, Paşaoğlu İ. Enalapril maleate in ischemia-reperfusion injury. 8th ISCP (Amsterdam, 28 Mar–1 Nis 1999). Cardiovasc Drugs Ther 13(1):49, 1999. Link: link yok
4) Yılmaz H, Ağaçhan B, Aydın M, Isbir CS, Isbir T. Association between apolipoprotein E and ACE genotype in CAD. 3rd Frontiers in Interventional Cardiology (Jerusalem, 27 Haz–1 Tem 1999). Int J Cardiovasc Interv 2(2):49, 1999. Link: link yok
5) Isbir CS, Doğan R, Farsak B, Aydın M, Demircin M. The effect of Captopril on membrane-bound enzymes in I/R injury. FEBS Free Radicals, NO and Antioxidants in Health and Disease (Antalya, 18–24 Eyl 1999). Link: link yok
6) Isbir CS, Doğan R, Farsak B, Aydın M. The effect of Lisinopril on myocardial I/R injury. FEBS Free Radicals, NO and Antioxidants in Health and Disease (Antalya, 18–24 Eyl 1999). Link: link yok
7) Aydın M, Öztürk O, Zeybek Ü, Yaylım İ, Ergen A, Ak K, Isbir CS. The late effect of I/R on oxidant/antioxidant system. Turkish-Italian Joint Meeting on Hypertension & Atherosclerosis (Antalya, 30 Mar–2 Nis 2000). Link: link yok
8) Isbir CS, Akgun S, Yılmaz H, Civelek A, Agachan B, Cobanoglu A. ACE gene polymorphism and failure of AV femoral shunts for hemodialysis. 2nd International Congress of the Vascular Access Society (Londra, 30 May–1 Haz 2001). Link: link yok
9) Akgün S, Civelek A, Isbir CS, Çobanoğlu A. Femoral arteriovenous PTFE grafts: Last choice for hemodialysis access. 2nd Congress of the Vascular Access Society (Londra, 30 May–1 Haz 2001). Link: link yok
10) Akgün S, Tekeli A, Civelek A, Isbir CS, Ak K, Cobanoglu A. Prevention of lung injury by FK506 following hind limb I/R in rats. 50th E.S.C.V.S. Congress (Budapeşte, 20–23 Haz 2001). Cardiovasc Surg 8:51, 2001. Link: link yok
11) Isbir CS, Ak K, Zeybek U, Akgün S, Diren S, Civelek A, Tekeli A, Sav A, Çobanoğlu A. Ischemic preconditioning and nicotinamide in spinal cord protection. 12th WSCTS (Luzern, 3–6 Mar 2002). Cardiovascular Engineering 7(1):114, 2002. Link: link yok
12) Isbir CS, Yildirim T, Akgün S, Civelek A, Arsan S. CABG in severe LV dysfunction. 12th WSCTS (Luzern, 3–6 Mar 2002). Cardiovascular Engineering 7(1):84, 2002. Link: link yok
13) Arsan S, Isbir S, Erentug V. Ascending aortic aneurysm repair: replacement or external wrapping. 13th WSCTS (San Diego, 1–5 Kas 2003). J Cardiovasc Surg 5(1):43, 2003. Link: link yok
14) Ak K, Akgün S, Tecimer T, Isbir S, Civelek A, Tekeli A, Atalan N, Arsan S. Histopathological risk factors for postoperative AF in cardiac surgery. 12th ASCVS (İstanbul, 18–22 Nis 2004). Link: link yok
15) Arsan S, Ak K, Akgün S, Civelek A, Isbir S, Aksoy N, Tekeli A, Yıldırım T. Reduction aortoplasty + external wrapping for tubular ascending AA with concomitant ops. 12th ASCVS (İstanbul, 18–22 Nis 2004). Link: link yok
16) Tekeli A, Isbir CS, Civelek A, Akgün S, Ergen A, Kurtkaya O, Sav A, Arsan S. Prevention of lung injury by Iloprost after hind limb I/R in rats. MACCS XVI (26–29 Eyl 2004). Heart Surgery Forum 7 (Suppl 2), 2005. Link: The Heart Surgery Forum (2005 Suppl)
17) Isbir CS, Ak K, Aksoy N, Tekeli A, Civelek A, Tetik S, Birkan Y, Adademir T, Arsan S. Acetylsalicylic acid resistance in CABG. Update in Cardiology & Cardiovascular Surgery (Bodrum, 29 Eyl–2 Eki 2005). Heart Surgery Forum 8(Suppl 1), 2005. Link: The Heart Surgery Forum (2005 Suppl)
18) Isbir CS, Tekeli A, Ak K, Ergen A, Yılmaz H, Adademir T, Civelek A, Atalan N, Arsan S. ACE gene polymorphism and acute renal dysfunction after CABG. 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
19) Tekeli A, Isbir S, Ak K, Atalan N, Adademir T, Civelek A, Arsan S. Does EuroSCORE predict major adverse events? 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
20) Tekeli A, Zeybek Ü, Agachan B, Ergen A, Ak K, Isbir S, Arsan S. IL-6 ve IL-8 polymorphisms after CABG: inflammatory cytokines? 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
21) Adademir T, Tekeli A, Ak K, Birkan Y, Atalan N, Civelek A, Isbir CS, Arsan S. Effect of AKI on early mortality after cardiac surgery. 2nd Update in Cardiology & Cardiovascular Surgery (20–24 Eyl 2006). Heart Surgery Forum 9(1):S9, 2006. Link: link yok
22) Ak K, Adademir T, Gürsu O, Tekeli A, Atalan N, Tetik S, Isbir S, Arsan S. TEG-based transfusion algorithm reduces blood product use after cardiac surgery. 4th Update in Cardiology & Cardiovascular Surgery (28 Kas–2 Ara 2008). Heart Surgery Forum 11(2):S2, 2008. Link: The Heart Surgery Forum (2008 Suppl)
23) Ak K, Adademir T, Isbir S, Gürsu O, Tekeli A, Atalan N, Arsan S. Impact of preoperative anemia on outcome after CABG. Update in Cardiology & Cardiovascular Surgery (Antalya, 28 Kas–2 Ara 2008). Heart Surg Forum 11(2):S52, 2008. Link: The Heart Surgery Forum (2008 Suppl)
24) Ak K, Isbir S, Tekeli A, Adademir T, Gürsu O, Güler A, Arsan S. Preoperative IABP support in high-risk CABG. Update in Cardiology & Cardiovascular Surgery (Antalya, 28 Kas–2 Ara 2008). Heart Surg Forum 11(2):S60, 2008. Link: The Heart Surgery Forum (2008 Suppl)
25) Ak K, Tetik Ş, Adademir T, Gürsu Ö, Güler A, Isbir S, Yardımcı T, Arsan S. Impact of early statin therapy on tPA and TFPI after CABG. 5th Update in Cardiology & Cardiovascular Surgery (Antalya, 24–28 Eyl 2009). Heart Surg Forum 12(1):S21, 2009. Link: The Heart Surgery Forum – 2009 Supplement (PDF içinde)
26) Arsan S, Ak K, Adademir T, Güler A, Isbir S. Autologous right PA wall for repair of absent PA (TOF+APV). 5th Update in Cardiology & Cardiovascular Surgery (Antalya, 24–28 Eyl 2009). Heart Surg Forum 12(1):S91, 2009. Link: The Heart Surgery Forum – 2009 Supplement (PDF içinde)
27) Ergen A, Kahraman TÖ, Tekeli A, Turan AN, Ekşi YE, Adıgüzel M, Isbir S, Isbir T. Plasma myeloperoxidase in MI. 4th International Congress of Molecular Medicine (İstanbul, 27–30 Haz 2011). Link: link yok
28) Kurnaz Ö, Yılmaz AH, Isbir S, Isbir T. PPAR-γ PRO12ALA ve LOX-1 K167N varyantları ve KAH. 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
29) Görmüş U, Kahraman TÖ, Isbir S, Tekeli A, Isbir T. MMP2 gen polimorfizmi ve mRNA düzeyi (yüzeyel varis). 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
30) Teker Akadam AB, Yılmaz HA, Arat A, Isbir S, Isbir T. Combined effects of ApoE and PCSK9 R496W in CHD. 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
31) Timirci-Kahraman O, Görmüş U, Ergen HA, Tekeli A, Isbir S, Isbir T. mRNA levels of elastin, fibulin-5, LOXL-1, MMP-2/9 in varicose vein. 22nd IUBMB & 37th FEBS (Sevilla, 4–9 Eyl 2012). Link: link yok
32) Birkan Y, Isbir S, Ak K, Elçi E, Dericioğlu O, Arsan S. CD34(+) pluripotent MSC therapy in chronic critical limb ischemia. 14th Asian Society for Vascular Surgery (İstanbul, 26–29 Eki 2013). Link: link yok
33) Isbir S, Baltacioglu F, Ak K, Birkan Y, Elçi E, Gürsu Ö, Kırca G, Dericioğlu O, Arsan S. Five-year results of EVAR for AAA (single center). 14th ASVS (İstanbul, 26–29 Eki 2013). Link: link yok
34) Isbir S, Baltacioglu F, Ak K, Birkan Y, Elçi E, Gürsu Ö, Kırca G, Dericioğlu O, Arsan S. Endovascular graft repair of thoracic aortic pathologies (single center). 14th ASVS (İstanbul, 26–29 Eki 2013). Link: link yok
35) Öztürk NY, Ak K, Erkek N, Isbir S, Arsan S. VV-ECMO in pediatric ICU: early experience. 1st International Critical Care & Emergency Medicine Congress (İstanbul, 6–8 Kas 2013). Link: link yok
36) Yalındağ NO, Ak K, Besci T, Keleş B, Kolbaş N, Erkek N, Isbir S, Arsan S. VV-ECLS for infant with ARDS & airleaks (first success). 2nd EuroELSO (Stockholm, 8–11 May 2013). Int J Artif Organs 36(4):293, 2013. Link: link yok
37) Öztürk NO, Ak K, Yasa U, Barys S, Isbir S, Arsan S, Erkek N, Barlan İ. VV-ECLS weaning without anticoagulation (IPEX, child). 2nd EuroELSO (Stockholm, 8–11 May 2013). Int J Artif Organs 36(4):294, 2013. Link: link yok
38) Isbir S, Baltacioglu F, Ak K, Kararmaz A, Elçi E, Arsan S. Hybrid procedures for extensive aortic pathologies (22 hasta). AATS Aortic Symposium (New York, 24–25 Nis 2014). Link: link yok
39) Birkan Y, Ak K, Dericioğlu O, Isbir S, Arsan S. CD34(+) MSC therapy in chronic critical limb ischemia. 11th International Congress of Update in Cardiology & Cardiovascular Surgery (26–29 Mar 2015). JACC Suppl S6, 2015. Link: link yok
40) Isbir S. Hybrid debranching and endovascular repair of extensive TAAA. EuroPCR (Paris, 19–21 May 2015). Link: EuroPCR 2015 Abstract Book (PDF)
41) Isbir S, Birkan Y. EVH + MECC + Autotransfusion. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
42) Isbir S. Hybrid thoracoabdominal aortic aneurysm repair. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
43) Isbir S. Sutureless valve replacement as a concomitant procedure. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
- Аннотация: Влияние использования внутренней грудной артерии на результаты сочетанного протезирования аортального клапана и КШ (тезисы AHA).
2) Isbir CS, Doğan R, Demircin M, Paşaoğlu İ. The effect of Aprotinin in ischemia-reperfusion injury: Role of membrane bound enzymes. 8th International Symposium on Cardiovascular Pharmacotherapy (Amsterdam, 28 Mar–1 Nis 1999). Cardiovasc Drugs Ther 13(1):48, 1999. Link: link yok
- Аннотация: Влияние апротинина на мембранные ферменты при ишемически-реперфузионном повреждении.
3) Isbir CS, Doğan R, Tuncer M, Farsak B, Kılınç K, Aydın M, Paşaoğlu İ. Enalapril maleate in ischemia-reperfusion injury. 8th ISCP (Amsterdam, 28 Mar–1 Nis 1999). Cardiovasc Drugs Ther 13(1):49, 1999. Link: link yok
- Аннотация: Влияние эналаприла на ишемически-реперфузионное повреждение в эксперименте.
4) Yılmaz H, Ağaçhan B, Aydın M, Isbir CS, Isbir T. Association between apolipoprotein E and ACE genotype in CAD. 3rd Frontiers in Interventional Cardiology (Jerusalem, 27 Haz–1 Tem 1999). Int J Cardiovasc Interv 2(2):49, 1999. Link: link yok
- Аннотация: Связь генотипов ApoE и ACE с ИБС.
5) Isbir CS, Doğan R, Farsak B, Aydın M, Demircin M. The effect of Captopril on membrane-bound enzymes in I/R injury. FEBS Free Radicals, NO and Antioxidants in Health and Disease (Antalya, 18–24 Eyl 1999). Link: link yok
- Аннотация: Каптоприл и мембранные ферменты при ишемически-реперфузионном повреждении.
6) Isbir CS, Doğan R, Farsak B, Aydın M. The effect of Lisinopril on myocardial I/R injury. FEBS Free Radicals, NO and Antioxidants in Health and Disease (Antalya, 18–24 Eyl 1999). Link: link yok
- Аннотация: Влияние лизиноприла на ишемически-реперфузионное повреждение миокарда.
7) Aydın M, Öztürk O, Zeybek Ü, Yaylım İ, Ergen A, Ak K, Isbir CS. The late effect of I/R on oxidant/antioxidant system. Turkish-Italian Joint Meeting on Hypertension & Atherosclerosis (Antalya, 30 Mar–2 Nis 2000). Link: link yok
- Аннотация: Отдалённые прооксидантные и антиоксидантные эффекты ишемии и реперфузии.
8) Isbir CS, Akgun S, Yılmaz H, Civelek A, Agachan B, Cobanoglu A. ACE gene polymorphism and failure of AV femoral shunts for hemodialysis. 2nd International Congress of the Vascular Access Society (Londra, 30 May–1 Haz 2001). Link: link yok
- Аннотация: Связь полиморфизма ACE с несостоятельностью артериовенозного шунта.
9) Akgün S, Civelek A, Isbir CS, Çobanoğlu A. Femoral arteriovenous PTFE grafts: Last choice for hemodialysis access. 2nd Congress of the Vascular Access Society (Londra, 30 May–1 Haz 2001). Link: link yok
- Аннотация: Результаты применения бедренных артериовенозных протезов из ПТФЭ для сосудистого доступа.
10) Akgün S, Tekeli A, Civelek A, Isbir CS, Ak K, Cobanoglu A. Prevention of lung injury by FK506 following hind limb I/R in rats. 50th E.S.C.V.S. Congress (Budapeşte, 20–23 Haz 2001). Cardiovasc Surg 8:51, 2001. Link: link yok
- Аннотация: Предотвращение повреждения лёгких с помощью FK506 у крыс.
11) Isbir CS, Ak K, Zeybek U, Akgün S, Diren S, Civelek A, Tekeli A, Sav A, Çobanoğlu A. Ischemic preconditioning and nicotinamide in spinal cord protection. 12th WSCTS (Luzern, 3–6 Mar 2002). Cardiovascular Engineering 7(1):114, 2002. Link: link yok
- Аннотация: Экспериментальная защита спинного мозга с помощью ишемического прекондиционирования и никотинамида.
12) Isbir CS, Yildirim T, Akgün S, Civelek A, Arsan S. CABG in severe LV dysfunction. 12th WSCTS (Luzern, 3–6 Mar 2002). Cardiovascular Engineering 7(1):84, 2002. Link: link yok
- Аннотация: Результаты КШ у пациентов с низкой фракцией выброса.
13) Arsan S, Isbir S, Erentug V. Ascending aortic aneurysm repair: replacement or external wrapping. 13th WSCTS (San Diego, 1–5 Kas 2003). J Cardiovasc Surg 5(1):43, 2003. Link: link yok
- Аннотация: Варианты хирургического лечения аневризм восходящей аорты.
14) Ak K, Akgün S, Tecimer T, Isbir S, Civelek A, Tekeli A, Atalan N, Arsan S. Histopathological risk factors for postoperative AF in cardiac surgery. 12th ASCVS (İstanbul, 18–22 Nis 2004). Link: link yok
- Аннотация: Гистопатологические маркеры послеоперационной фибрилляции предсердий.
15) Arsan S, Ak K, Akgün S, Civelek A, Isbir S, Aksoy N, Tekeli A, Yıldırım T. Reduction aortoplasty + external wrapping for tubular ascending AA with concomitant ops. 12th ASCVS (İstanbul, 18–22 Nis 2004). Link: link yok
- Аннотация: Редукционная аортопластика и наружное окутывание при умеренном расширении восходящей аорты.
16) Tekeli A, Isbir CS, Civelek A, Akgün S, Ergen A, Kurtkaya O, Sav A, Arsan S. Prevention of lung injury by Iloprost after hind limb I/R in rats. MACCS XVI (26–29 Eyl 2004). Heart Surgery Forum 7 (Suppl 2), 2005. Link: The Heart Surgery Forum (2005 Suppl)
- Аннотация: Защита лёгких илопростом в эксперименте.
17) Isbir CS, Ak K, Aksoy N, Tekeli A, Civelek A, Tetik S, Birkan Y, Adademir T, Arsan S. Acetylsalicylic acid resistance in CABG. Update in Cardiology & Cardiovascular Surgery (Bodrum, 29 Eyl–2 Eki 2005). Heart Surgery Forum 8(Suppl 1), 2005. Link: The Heart Surgery Forum (2005 Suppl)
- Аннотация: Резистентность к аспирину у пациентов при КШ.
18) Isbir CS, Tekeli A, Ak K, Ergen A, Yılmaz H, Adademir T, Civelek A, Atalan N, Arsan S. ACE gene polymorphism and acute renal dysfunction after CABG. 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
- Аннотация: Связь полиморфизма ACE с ОПП после КШ.
19) Tekeli A, Isbir S, Ak K, Atalan N, Adademir T, Civelek A, Arsan S. Does EuroSCORE predict major adverse events? 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
- Аннотация: Прогнозирование серьёзных нежелательных событий с помощью EuroSCORE.
20) Tekeli A, Zeybek Ü, Agachan B, Ergen A, Ak K, Isbir S, Arsan S. IL-6 ve IL-8 polymorphisms after CABG: inflammatory cytokines? 16th WSCTS (Ottawa, 17–20 Ağu 2006). Link: link yok
- Аннотация: Полиморфизмы генов цитокинов и воспаление после КШ.
21) Adademir T, Tekeli A, Ak K, Birkan Y, Atalan N, Civelek A, Isbir CS, Arsan S. Effect of AKI on early mortality after cardiac surgery. 2nd Update in Cardiology & Cardiovascular Surgery (20–24 Eyl 2006). Heart Surgery Forum 9(1):S9, 2006. Link: link yok
- Аннотация: Связь ОПП с ранней летальностью.
22) Ak K, Adademir T, Gürsu O, Tekeli A, Atalan N, Tetik S, Isbir S, Arsan S. TEG-based transfusion algorithm reduces blood product use after cardiac surgery. 4th Update in Cardiology & Cardiovascular Surgery (28 Kas–2 Ara 2008). Heart Surgery Forum 11(2):S2, 2008. Link: The Heart Surgery Forum (2008 Suppl)
- Аннотация: Алгоритм на основе тромбоэластографии (ТЭГ) снижает потребность в переливаниях.
23) Ak K, Adademir T, Isbir S, Gürsu O, Tekeli A, Atalan N, Arsan S. Impact of preoperative anemia on outcome after CABG. Update in Cardiology & Cardiovascular Surgery (Antalya, 28 Kas–2 Ara 2008). Heart Surg Forum 11(2):S52, 2008. Link: The Heart Surgery Forum (2008 Suppl)
- Аннотация: Предоперационная анемия связана с неблагоприятными исходами.
24) Ak K, Isbir S, Tekeli A, Adademir T, Gürsu O, Güler A, Arsan S. Preoperative IABP support in high-risk CABG. Update in Cardiology & Cardiovascular Surgery (Antalya, 28 Kas–2 Ara 2008). Heart Surg Forum 11(2):S60, 2008. Link: The Heart Surgery Forum (2008 Suppl)
- Аннотация: Опыт внутриаортальной баллонной контрпульсации при КШ высокого риска.
25) Ak K, Tetik Ş, Adademir T, Gürsu Ö, Güler A, Isbir S, Yardımcı T, Arsan S. Impact of early statin therapy on tPA and TFPI after CABG. 5th Update in Cardiology & Cardiovascular Surgery (Antalya, 24–28 Eyl 2009). Heart Surg Forum 12(1):S21, 2009. Link: The Heart Surgery Forum – 2009 Supplement (PDF içinde)
- Аннотация: Изменения tPA и TFPI при раннем назначении статинов.
26) Arsan S, Ak K, Adademir T, Güler A, Isbir S. Autologous right PA wall for repair of absent PA (TOF+APV). 5th Update in Cardiology & Cardiovascular Surgery (Antalya, 24–28 Eyl 2009). Heart Surg Forum 12(1):S91, 2009. Link: The Heart Surgery Forum – 2009 Supplement (PDF içinde)
- Аннотация: Реконструкция с использованием аутологичного участка стенки лёгочной артерии: клинический случай.
27) Ergen A, Kahraman TÖ, Tekeli A, Turan AN, Ekşi YE, Adıgüzel M, Isbir S, Isbir T. Plasma myeloperoxidase in MI. 4th International Congress of Molecular Medicine (İstanbul, 27–30 Haz 2011). Link: link yok
- Аннотация: Связь уровня миелопероксидазы (MPO) с инфарктом миокарда.
28) Kurnaz Ö, Yılmaz AH, Isbir S, Isbir T. PPAR-γ PRO12ALA ve LOX-1 K167N varyantları ve KAH. 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
- Аннотация: Связь генетических вариантов с ИБС.
29) Görmüş U, Kahraman TÖ, Isbir S, Tekeli A, Isbir T. MMP2 gen polimorfizmi ve mRNA düzeyi (yüzeyel varis). 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
- Аннотация: Связь MMP2 с варикозным расширением вен.
30) Teker Akadam AB, Yılmaz HA, Arat A, Isbir S, Isbir T. Combined effects of ApoE and PCSK9 R496W in CHD. 4th ICoMM (İstanbul, 27–30 Haz 2011). Link: link yok
- Аннотация: Сочетания вариантов ApoE и PCSK9 и их связь с ИБС.
31) Timirci-Kahraman O, Görmüş U, Ergen HA, Tekeli A, Isbir S, Isbir T. mRNA levels of elastin, fibulin-5, LOXL-1, MMP-2/9 in varicose vein. 22nd IUBMB & 37th FEBS (Sevilla, 4–9 Eyl 2012). Link: link yok
- Аннотация: Экспрессия генов, связанных с внеклеточным матриксом, при варикозном расширении вен.
32) Birkan Y, Isbir S, Ak K, Elçi E, Dericioğlu O, Arsan S. CD34(+) pluripotent MSC therapy in chronic critical limb ischemia. 14th Asian Society for Vascular Surgery (İstanbul, 26–29 Eki 2013). Link: link yok
- Аннотация: Лечение критической ишемии конечности с применением CD34(+) мезенхимальных стволовых клеток.
33) Isbir S, Baltacioglu F, Ak K, Birkan Y, Elçi E, Gürsu Ö, Kırca G, Dericioğlu O, Arsan S. Five-year results of EVAR for AAA (single center). 14th ASVS (İstanbul, 26–29 Eki 2013). Link: link yok
- Аннотация: Пятилетний опыт EVAR в одном центре.
34) Isbir S, Baltacioglu F, Ak K, Birkan Y, Elçi E, Gürsu Ö, Kırca G, Dericioğlu O, Arsan S. Endovascular graft repair of thoracic aortic pathologies (single center). 14th ASVS (İstanbul, 26–29 Eki 2013). Link: link yok
- Аннотация: Опыт применения эндоваскулярных протезов в грудной аорте.
35) Öztürk NY, Ak K, Erkek N, Isbir S, Arsan S. VV-ECMO in pediatric ICU: early experience. 1st International Critical Care & Emergency Medicine Congress (İstanbul, 6–8 Kas 2013). Link: link yok
- Аннотация: Опыт вено-венозной ЭКМО в детской реанимации.
36) Yalındağ NO, Ak K, Besci T, Keleş B, Kolbaş N, Erkek N, Isbir S, Arsan S. VV-ECLS for infant with ARDS & airleaks (first success). 2nd EuroELSO (Stockholm, 8–11 May 2013). Int J Artif Organs 36(4):293, 2013. Link: link yok
- Аннотация: Успешное применение вено-венозной экстракорпоральной поддержки жизни (VV-ECLS) у младенца с ОРДС.
37) Öztürk NO, Ak K, Yasa U, Barys S, Isbir S, Arsan S, Erkek N, Barlan İ. VV-ECLS weaning without anticoagulation (IPEX, child). 2nd EuroELSO (Stockholm, 8–11 May 2013). Int J Artif Organs 36(4):294, 2013. Link: link yok
- Аннотация: Отлучение от VV-ECLS без антикоагуляции: клинический случай.
38) Isbir S, Baltacioglu F, Ak K, Kararmaz A, Elçi E, Arsan S. Hybrid procedures for extensive aortic pathologies (22 hasta). AATS Aortic Symposium (New York, 24–25 Nis 2014). Link: link yok
- Аннотация: Гибридный подход при распространённом поражении аорты.
39) Birkan Y, Ak K, Dericioğlu O, Isbir S, Arsan S. CD34(+) MSC therapy in chronic critical limb ischemia. 11th International Congress of Update in Cardiology & Cardiovascular Surgery (26–29 Mar 2015). JACC Suppl S6, 2015. Link: link yok
- Аннотация: Лечение критической ишемии конечности стволовыми клетками: тезисы конгресса.
40) Isbir S. Hybrid debranching and endovascular repair of extensive TAAA. EuroPCR (Paris, 19–21 May 2015). Link: EuroPCR 2015 Abstract Book (PDF)
- Аннотация: Гибридный дебранчинг и эндоваскулярное лечение торакоабдоминальных аневризм аорты (ТААА).
41) Isbir S, Birkan Y. EVH + MECC + Autotransfusion. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
- Аннотация: Опыт эндоскопического выделения вен, MECC и аутотрансфузии в малоинвазивной хирургии.
42) Isbir S. Hybrid thoracoabdominal aortic aneurysm repair. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
- Аннотация: Опыт гибридного лечения ТААА.
43) Isbir S. Sutureless valve replacement as a concomitant procedure. 2nd Minimally Invasive & Robotic CV Surgery Symposium & ISMICS 2015 Winter Workshop (İstanbul, 11–13 Ara 2015). Link: link yok
- Аннотация: Одновременное бесшовное протезирование клапана.
